Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs00983173
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NFN![]() | 6-[[(2-ETHOXY-1-NAPHTHALENYL)CARBONYL]AMINO]- 3,3-DIMETHYL-7-OXO-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE- 2-CARBOXYLATE | A | 1T9W | 0.73 | ![]() |
11M![]() | 1-(1'-{[3-(methylsulfanyl)-2-benzothiophen- 1-yl]carbonyl}spiro[1-benzofuran- 3,4'-piperidin]-5-yl)methanamine | A,B,C,D | 2ZEB | 0.87 | ![]() |
2FF![]() | (5-(aminomethyl)-2H-spiro[benzofuran- 3,4'-piperidine]-1'-yl)(5-(phenylethynyl)furan- 2-yl)methanone | A,B,C,D | 2ZA5 | 0.73 | ![]() |
RAL![]() | RALOXIFENE | A,B | 2JFA | 0.74 | ![]() |
RAL![]() | RALOXIFENE | A,B | 1ERR | 0.74 | ![]() |
RAL![]() | RALOXIFENE | A,B | 2QXS | 0.74 | ![]() |
RAL![]() | RALOXIFENE | A | 1QKN | 0.74 | ![]() |
11N![]() | 1-[1'-(3-phenylacryloyl)spiro[1- benzofuran-3,4'-piperidin]-5-yl]methanamine | A,B,C,D | 2ZEC | 0.72 | ![]() |
LLB![]() | [6-hydroxy-2-(4-hydroxyphenyl)- 1-benzothien-3-yl]{4-[2-(4-methylpiperidin- 1-yl)ethoxy]phenyl}methanone | A,B | 2R6W | 0.74 | ![]() |
FLQ![]() | N-[6-(ACETYLAMINO)HEXYL]-3',6'- DIHYDROXY-3-OXO-3H-SPIRO[2-BENZOFURAN- 1,9'-XANTHENE]-6-CARBOXAMIDE | C | 2FDC | 0.73 | ![]() |
LLC![]() | [6-hydroxy-2-(4-hydroxyphenyl)- 1-benzothien-3-yl][4-(2-pyrrolidin- 1-ylethoxy)phenyl]methanone | A,B | 2R6Y | 0.75 | ![]() |
SM2![]() | (1R)-1-(2-THIENYLACETYLAMINO)-1- (3-CARBOXYPHENYL)METHYLBORONIC ACID | A,B | 1PI5 | 0.71 | ![]() |
SM2![]() | (1R)-1-(2-THIENYLACETYLAMINO)-1- (3-CARBOXYPHENYL)METHYLBORONIC ACID | A | 1NXY | 0.71 | ![]() |
SM2![]() | (1R)-1-(2-THIENYLACETYLAMINO)-1- (3-CARBOXYPHENYL)METHYLBORONIC ACID | A,B | 1MXO | 0.71 | ![]() |
SM2![]() | (1R)-1-(2-THIENYLACETYLAMINO)-1- (3-CARBOXYPHENYL)METHYLBORONIC ACID | A,B | 1YM1 | 0.71 | ![]() |
ILC![]() | A | 2FPV | 0.72 | ![]() | |
ILF![]() | A | 2FPY | 0.71 | ![]() | |
B98![]() | (3R)-3-(aminomethyl)-9-methoxy- 1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2- e][1,4]diazepin-5-one | A | 3FZ1 | 0.75 | ![]() |
B98![]() | (3R)-3-(aminomethyl)-9-methoxy- 1,2,3,4-tetrahydro-5H-[1]benzothieno[3,2- e][1,4]diazepin-5-one | X | 3FYK | 0.75 | ![]() |
462![]() | N-[amino(imino)methyl]-2-[2-(2- chlorophenyl)-4-(4-propoxyphenyl)- 3-thienyl]acetamide | A | 2QU3 | 0.7 | ![]() |
R22![]() | 4-(3,5-DIMETHYLPHENOXY)-5-(FURAN- 2-YLMETHYLSULFANYLMETHYL)-3-IODO- 6-METHYLPYRIDIN-2(1H)-ONE | A,B | 2BE2 | 0.71 | ![]() |
HWG![]() | N-(TERT-BUTYL)-3,5-DIMETHYL-N'- [(5-METHYL-2,3-DIHYDRO-1,4-BENZODIOXIN- 6-YL)CARBONYL]BENZOHYDRAZIDE | A,D | 1R20 | 0.7 | ![]() |
NBF![]() | [(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID | A | 1NY0 | 0.73 | ![]() |
NBF![]() | [(2-ETHOXY-1-NAPHTHOYL)AMINO]METHYLBORONIC ACID | A,B | 1YMS | 0.73 | ![]() |
MZ4![]() | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(3-METHOXYPHENYL)SULFONYL](2- THIENYLMETHYL)AMINO}PROPYL]-3,4- DIHYDROXYBENZAMIDE | A,B | 2QI1 | 0.75 | ![]() |
L75![]() | N-[2(R)-HYDROXY-1(S)-INDANYL]-2(R)- PHENYLMETHYL-4(S)-HYDROXY-5-[4- [2-BENZOFURANYLMETHYL]-2(S)-[TERT- BUTYLAMINOCARBONYL]-PIPERAZINYL]- PENTANEAMIDE | B | 1C70 | 0.7 | ![]() |
154![]() | (2S)-2-[(5-BENZOFURAN-2-YL-THIOPHEN- 2-YLMETHYL)-(2,4-DICHLORO-BENZOYL)- AMINO]-3-PHENYL-PROPIONIC ACID | A,B | 1NHV | 0.73 | ![]() |
MZ3![]() | N-[(1S,2R)-1-BENZYL-2-HYDROXY-3- {[(3-METHOXYPHENYL)SULFONYL](2- THIENYLMETHYL)AMINO}PROPYL]-3-FLUORO- 2-METHYLBENZAMIDE | A,B | 2QI0 | 0.77 | ![]() |